Navigation Links
HIV conquers immune system faster than previously realized
Date:7/18/2008

tter idea of when to do it."

The conclusion comes from the study of 30 people who were newly-infected with HIV-1. Plasma from these individuals was sampled every three days for several months before, during, and after the "ramp-up" phase of infection, when HIV-1 is multiplying rapidly and heading toward its peak viral load. In measuring the levels of four products of CD4 T cell death during this period in these samples, they were able to track and establish a timetable of the virus's destructive path.

The four byproducts of CD4 T cell death include TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), Fas ligand, TNF receptor type 2 and plasma microparticles, tiny bits of cell membrane that are broken up and left floating around in the plasma when the cell dies and breaks apart.

The researchers found that TRAIL levels increased significantly a full week (7.2. days) before peak viral load, which is approximately 17 days after HIV-1 transmission, suggesting that during the earliest period of infection, called the eclipse phase, TRAIL may actually initiate or hasten HIV-1's destruction of CD4 T cells. In contrast, they found that the levels of the other three cell death products were most significantly elevated during peak viral load.

"What this demonstrates is that significant T cell death is occurring much earlier during this period than we previously believed, and that TRAIL itself may be a co-conspirator in enhancing cell death," Haynes said. "This leads us to believe that the time frame for successful intervention has to move even close to the point of infection."

Researchers also examined the effects of cell death products upon B cells, another arm of the immune system responsible for the creation of antibodies. Previous studies have shown that the antibody response to HIV-1 is "too little, too late" appearing after the virus has peaked and after the reservoir of infected T cells has already been est
'/>"/>

Contact: Michelle Gailiun
michelle.gailiun@duke.edu
919-660-1306
Duke University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Peptimmune Announces the Second Close of Series D Private Financing
2. Brain Cancer Vaccines Immune Response Key to Outcomes
3. Brain cancer study: Magnitude of post-vaccine immune response linked to clinical outcomes
4. Researchers link Huntingtons disease to overactive immune response in the brain
5. Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems
6. Multi-target immune therapy improves outcomes of severe lupus nephritis
7. Immune Molecule Key to Preventing Organ Rejection
8. Nasal spray using bodys immune system provides hope of cure for common cold
9. Immune Design Announces $18 Million Series A Financing
10. Autoimmune Disease Treatment May Not Dampen Immune System
11. Immune molecule that plays a powerful role in avoiding organ rejection identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...OCHESTER, N.Y., Jan. 8 ...r women and African-Americans, but the reasons lon...nly part of the differences for such patients comp...ng to results published in the Jan. 1 issue of the...ark question for doctors and patients: If age, tum...
(Date:1/8/2009)...OCHESTER, N.Y., Jan. 8 ...) has received a U.S. patent for a diagnostic tech...organisms such as bacteria and other infectious ag...ed life sciences company, is the exclusive worldwi...ompany,s technology platform -- called NanoLantern...
(Date:1/8/2009)...TON Jan. 8, 2009 While the U.S. Food and Drug Ad...l of new medicines, the complex nature of diseases...s resulted in longer clinical development times, a... Development. , The average time for the FDA to ...5-07 period, but longer average clinical phase tim...
(Date:1/8/2009)... RingingCedarsofRussia.org rel...ld pressed oil of Siberian Cedar nuts, also known ...super food. In a clinical trial conducted by Profe...tal of Novosibirsk # 1 with wild harvested, cold p...avorable results were found. Pine nut oil was prov...
Breaking Medicine News(10 mins):Health News:Why Bladder Cancer Is Deadlier for Some 2Health News:Why Bladder Cancer Is Deadlier for Some 3Health News:Why Bladder Cancer Is Deadlier for Some 4Health News:URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology 2Health News:URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology 3Health News:URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology 4Health News:New drug development still takes 8 years despite faster FDA review, according to Tufts CSDD 2Health News:RingingCedarsofRussia.org Releases Pine Nut Oil Research Showing That Digestive and Stomach Disorders Respond to Unique Super Food: Siberian Pine Nut Oil 2
...has shown that stress may be one of the main reaso...housands of otherwise healthy women in Britain fro...o conceive could increase their chances greatly by...e stated yesterday that many women who are struggl...
...ies report – 'In Zambia, people in the tourist res...irus attack after finding dead chickens at the own...etary at the health ministry, said 'No confirmed e...ugh investigation of the outbreak'. The number of...
... in fish oil is found to enhance educational achie...researchers at the University of South Australia /...ffering from Attention Deficit hyperactivity disor... better to Omega 3 fish oils than to the drug Rita...
...the killer of Lin and Megan Russell has petitioned... mental health report// public since it would be m...serving life for the two murders committed a decad... QC said that the parts of the mental health repor...
Other Medicine News:Health News:Stress Affects Fertility 2Health News:Stress Affects Fertility 3
(Date:1/8/2009)...idate Novel Gene Expression Biomarkers Involved in...tform , , FREMONT, Calif., Jan. 8 /PRNewswire-F...in Board: WGBS), a leading developer of state-of-t...nd stem cell research systems, today announced the...versity of Texas Southwestern Medical Center for ...
(Date:1/7/2009)...USNewswire/ -- Scientists have identified mutation...pse in children with acute lymphoblastic leukemia ...er research is needed to determine how changes in ...emia relapse, the findings are likely to provide t... risk of treatment failure. By using a molecular t...
(Date:1/7/2009)...ewswire/ -- Circassia Ltd, a specialty,biopharmac...re, today,announced that following successful cli...e(R) anti-allergy technology, the company has now ... II clinical trial in cat allergy. The,study, whi...ts with confirmed,cat allergies, and all the part...
(Date:1/6/2009)...USNewswire/ -- Sequella, Inc., a clinical-stage bi...demic potential, announced today that SQ109, its l...is (TB), was the first drug approved for evaluatio...Dynport Vaccine Company LLC and Quintiles Transnat...tute of Allergy and Infectious Diseases (NIAID), N...
Breaking Medicine Technology:WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract Extension 1471 1Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract Extension 1471 2The Oral Cancer Foundation Urges HPV Vaccination for Males 636 1The Oral Cancer Foundation Urges HPV Vaccination for Males 636 2The Oral Cancer Foundation Urges HPV Vaccination for Males 636 3Inhaler Eased Lung Problems in 9 11 Workers 4498 1Inhaler Eased Lung Problems in 9 11 Workers 4498 2Inhaler Eased Lung Problems in 9 11 Workers 4498 3Georgetown leads major effort to combat disparities in DC stroke care 4496 1Georgetown leads major effort to combat disparities in DC stroke care 4496 2Georgetown leads major effort to combat disparities in DC stroke care 4496 3
...alidomide in Multiple Myeloma,Presented at the Ame...ting, CHICAGO, June 04, 2007 /PRNewswire-FirstCall... results of a Phase III study,demonstrating that t...roves overall survival (OS) by 17.6 months in pati...e myeloma compared to the,current standard of care...
...ke After Sleep Onset and Total Sleep,Time, and Key...ent,Sleep, Were Met at Both Doses, HAMBURG, German...irstCall/ -- Evotec AG announced today positive,to...ial of EVT 201,in patients with chronic primary in...odulator (pPAM) of the GABAA receptor complex.,The...
Other Medicine Technology:Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 2Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 3Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 4Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 5Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 6Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 2Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 3Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 4
Marlin' Cervical Orthosis ensures comfort and immobilization with its semirigid molded polyethylene anterior frame and occipital component. Two-piece design allows free air flow and easy application.
Exo-Static™ Collar for cervical stabilization from neutral to full positions. Automatic adjustment allows widening under occiput when collar is lowered under chin. Velcro® fasterner.,Exo-S
...bilization for muscles and ligaments to aid in rel...ic abdominal belt provides additional uplift suppo.... Two semi-rigid metal stays are adjustable and s... for optimum wearing comfort. Easy hook and loop ...
... the proven system for the non-operative treatment...r with the system, BBI offers the Boston Brace Cou... Boston Scoliosis Brace is available in 30 stock s...d by cast or measurements. For finished braces, x-...
Medicine Products: